Healthcare Fraud Analytics Market - Global Forecast 2025-2032

The healthcare fraud analytics market is rapidly gaining traction as organizations recognize the growing need to secure financial systems and ensure compliance amid increasing fraud threats. By advancing detection capabilities and supporting stakeholder collaboration, this market plays a pivotal role in modern healthcare operations.

Market Snapshot: Healthcare Fraud Analytics Market Growth Trends

The Healthcare Fraud Analytics Market grew from USD 8.18 billion in 2024 to USD 9.85 billion in 2025. It is expected to advance at a CAGR of 20.41%, reaching USD 36.16 billion by 2032. The primary keyword, healthcare fraud analytics market, reflects the critical need for sophisticated analytical solutions as the healthcare ecosystem faces continually evolving financial risks. Key market drivers include digital transformation, escalating compliance mandates, and the scale of fraudulent activity prompting investments across payers, providers, and regulators.

Scope & Segmentation

This report delivers comprehensive insight into market dynamics by covering the following segments:

• Components: Services, Software
• Deployment Mode: Cloud, Hybrid, On Premise
• End Users: Government Agencies, Payers, Pharmaceutical Companies, Providers, Third Party Administrators
• Analytics Type: Compliance, Detection, Investigation, Prevention, Recovery, Risk Assessment
• Applications: Billing and Coding Analytics, Claim Analytics, Network Analytics, Patient Analytics, Provider Analytics
• Regions: Americas (including North America and Latin America), Europe Middle East & Africa (Europe, Middle East, Africa), Asia-Pacific
• Key Companies: Fair Isaac Corporation, SAS Institute Inc., Optum Inc., Cotiviti LLC, International Business Machines Corporation, LexisNexis Risk Solutions Inc., Experian Information Solutions Inc., SAP SE, Change Healthcare LLC, DXC Technology Company

The segmentation supports in-depth analysis of sector-specific and regional priorities, with diverse deployment models and analytics functions designed to meet regulatory and operational demands.

Key Takeaways for Senior Decision-Makers

• Adoption of AI and machine learning is accelerating as healthcare stakeholders confront increasingly complex fraud schemes and the limitations of rule-based detection approaches.
• Integration of claims, billing, and electronic health records into unified analytics platforms enhances operational transparency and enables proactive fraud prevention while maintaining data governance standards.
• Cloud-native and hybrid deployment models offer scalable analytics processing and data flexibility, aiding organizations in meeting both security and compliance requirements across jurisdictions.
• Collaboration with third-party partners, such as pharmacy benefit managers and investigation firms, is driving ecosystem-wide resilience by enabling cross-entity detection and intelligence sharing.
• Segment-specific insights show that government agencies, payers, and pharmaceutical companies are investing in specialized fraud analytics workflows to streamline regulatory adherence and risk management.
• Regional variations in technology adoption highlight the importance of customizing platforms for local regulatory, billing, and operational contexts.

Tariff Impact: Navigating US Trade Tariffs in 2025

The imposition of new US trade tariffs in 2025 created cost pressures for both technology providers and healthcare organizations. Increased import duties on hardware led many vendors to shift towards subscription-based and cloud-native solutions. These strategies reduced dependency on capital investments and promoted agility in delivering analytics solutions. In parallel, procurement consortiums and alternative supply chain partnerships have emerged to help healthcare systems manage tariff-induced volatility and protect innovation investments.

Methodology & Data Sources

The report utilizes a rigorous methodology combining extensive secondary research, qualitative interviews with key industry stakeholders, and cross-verified client data. Scenario modeling, benchmark analysis, and advisory board peer reviews ensure that the findings remain relevant and credible for strategic business decisions.

Why This Report Matters

• Enables informed technology and procurement strategies by identifying high-impact market shifts and regulatory drivers.
• Facilitates competitive benchmarking and partnership selection through comprehensive company profiling and segmentation analysis.
• Supports cross-functional adoption of best-practice fraud detection and risk governance frameworks for sustained organizational protection.

Conclusion

Embedding advanced analytics within fraud prevention creates new efficiencies, strengthens stakeholder confidence, and supports regulatory compliance. Organizations that invest in integrated, scalable solutions will be well-equipped to mitigate risks and respond to future challenges in the dynamic healthcare environment.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.